Ketamine Augmentation of ECT in Treatment-Resistant Depression

Abroad (travel likely)RecruitingPHASE3

Conditions

Major Depressive Disorder · Treatment Resistant Depression

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

IRCCS Ospedale San Raffaele Turro, Milan, Italy
Contact: Study coordinator (Alberto AZ Zangrillo, MD) · zangrillo.alberto@hsr.it · 0226436154
Contact: Study coordinator (Cristina CC Colombo, MD) · colombo.cristina@hsr.it · 0226435278

Study leads

Alberto AZ Zangrillo, MD
Principal Investigator
Università Vita-Salute San Raffaele
Cristina CC Colombo, MD
Principal Investigator
IRCCS Ospedale San Raffaele Turro

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Study the Efficacy and Safety of the INtegral Cognitive REMediation Program (INCREM) for Depression

Depression · Depressive Disorder

Abroad (travel likely)RecruitingPHASE3

Barcelona, Spain

Natural History of Depression, Bipolar Disorder and Suicide Risk

Behavioral Symptoms · Suicide · Self-Injurious Behavior

Abroad (travel likely)Recruiting

Bethesda, United States

Accelerated iTBS for Major Depression

Major Depressive Disorder (MDD) · Treatment Resistant Depression (TRD)

Abroad (travel likely)Recruiting

Istanbul, Turkey (Türkiye)

Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol

Major Depressive Disorder With Excessive Daytime Sleepiness Symptoms

Abroad (travel likely)RecruitingPHASE3

Chino, United States · Redlands, United States